Description
IGF::CT::IGF HEPATITIS-HIV COST PER REPORTABLE RESULTS (CPRR).
Base award description: HEPATITIS-HIV COST PER REPORTABLE RESULTS (CPRR).
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2012-09-28+$135,900= $135,900
- Mod P000012013-06-12-$35,000= $100,900
- Mod P000022013-11-13-$11,267= $89,633
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2012-09-28 | +$135,900 | $135,900 | HEPATITIS-HIV COST PER REPORTABLE RESULTS (CPRR). |
| Mod P00001· FUNDING ONLY ACTION | 2013-06-12 | −$35,000 | $100,900 | IGF::CT::IGF HEPATITIS-HIV COST PER REPORTABLE RESULTS (CPRR). |
| Mod P00002· CLOSE OUT | 2013-11-13 | −$11,267 | $89,633 | IGF::CT::IGF HEPATITIS-HIV COST PER REPORTABLE RESULTS (CPRR). |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI JG5JF2JQJ121)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24126N0884 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $23,706 | FY2026 |
| 36C24126N0887 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $2,003 | FY2026 |
| 36C24126N0852 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $2,023 | FY2026 |
| 36C25926N0415 | NETWORK CONTRACT OFFICE 19 (36C259) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $113,988 | FY2026 |
| 36C26226N0611 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $1,339,307 | FY2026 |
| 36C24226N0602 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $326,624 | FY2026 |
Other recipients under Q301 from 629-NEW ORLEANS (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25615P0813 | AMERICAN NATIONAL RED CROSS, THE | 629-NEW ORLEANS | $325,689 | FY2015 |
| VA25614F0055 | QUEST DIAGNOSTICS INCORPORATED | 629-NEW ORLEANS | $1,685 | FY2014 |
| VA25613P0486 | PROMETHEUS LABORATORIES INC | 629-NEW ORLEANS | $8,500 | FY2013 |
| VA25613J0167 | POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLC | 629-NEW ORLEANS | $23,780 | FY2013 |
| VA25613J2551 | QUEST DIAGNOSTICS INCORPORATED | 629-NEW ORLEANS | $4,725 | FY2013 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25613J0016_3600_VA256BP0044_3600 · retrieved 2026-09-26.